» Articles » PMID: 34647152

The Intestinal Flora of Patients with GHPA Affects the Growth and the Expression of PD-L1 of Tumor

Overview
Date 2021 Oct 14
PMID 34647152
Citations 12
Authors
Affiliations
Soon will be listed here.
Abstract

Context: Pituitary adenoma (PA) is a common intracranial tumor. The evidence indicates that the tumor immune microenvironment (TIME) is associated with PA and that the intestinal flora influences other tumors' growth through interacting with the TIME. However, how the intestinal microbial flora contributes to the development of PA through the immune response is unknown.

Objective And Methods: Here we used high-throughput Illumina MiSeq sequencing targeting the V3-V4 region of the 16S ribosomal RNA gene to investigate the intestinal flora of patients with growth hormone-secreting pituitary adenoma (GHPA), nonfunctional pituitary adenoma (NFPA), and healthy controls. We determined their effects on tumor growth and the TIME. Fecal microbiota transplantation (FMT) was performed after adoptive transfer via peripheral blood mononuclear cells to tumor-bearing nude mice, which allowed the study of the immune response.

Result: We discovered differences in the structures and quantities of intestinal flora between patients with GHPA, patients with NFPA, and healthy controls. After FMT, the intestinal flora of GHPA patients promoted the growth of tumors in mouse models. The number of programmed cell death ligand 1 (PD-L1)-positive cells increased in tumor tissues as well as the extent of infiltration of CD8 cells. Increased numbers of CD3CD8 cells and increased levels of sPD-L1 were detected in peripheral blood.

Conclusion: These findings indicated that the intestinal flora of patients with GHPA promoted tumor growth and that the immune system may mediate this change.

Citing Articles

The gut microbiome in patients with Cushing's disease affects depression- and anxiety-like behavior in mice.

Nie D, Wang D, Wang Z, Fang Q, Wang H, Xie W Microbiome. 2024; 12(1):225.

PMID: 39482760 PMC: 11529176. DOI: 10.1186/s40168-024-01939-1.


Fecal microbiota transplantation alleviates food allergy in neonatal mice via the PD-1/PD-L1 pathway and change of the microbiota composition.

Huang J, Wang X, Zhang J, Li Q, Zhang P, Wu C World Allergy Organ J. 2024; 17(10):100969.

PMID: 39403173 PMC: 11471638. DOI: 10.1016/j.waojou.2024.100969.


Fecal microbial transplants as investigative tools in cancer.

Bohm M, Ramesh A, Pierre J, Cook K, Murphy E, Makowski L Am J Physiol Gastrointest Liver Physiol. 2024; 327(5):G711-G726.

PMID: 39301964 PMC: 11559651. DOI: 10.1152/ajpgi.00171.2024.


Analysis of gut microbiota-derived metabolites regulating pituitary neuroendocrine tumors through network pharmacology.

Cao M, Huang P, Xu L, Zhang Y Front Pharmacol. 2024; 15:1403864.

PMID: 39295931 PMC: 11408289. DOI: 10.3389/fphar.2024.1403864.


The Role of Bacteria in Central Nervous System Tumors: Opportunities and Challenges.

Zhang R, Li X, Zhang S Microorganisms. 2024; 12(6).

PMID: 38930435 PMC: 11205425. DOI: 10.3390/microorganisms12061053.


References
1.
. Structure, function and diversity of the healthy human microbiome. Nature. 2012; 486(7402):207-14. PMC: 3564958. DOI: 10.1038/nature11234. View

2.
Tanoue T, Morita S, Plichta D, Skelly A, Suda W, Sugiura Y . A defined commensal consortium elicits CD8 T cells and anti-cancer immunity. Nature. 2019; 565(7741):600-605. DOI: 10.1038/s41586-019-0878-z. View

3.
Klicznik M, Benedetti A, Gail L, Varkhande S, Holly R, Laimer M . A novel humanized mouse model to study the function of human cutaneous memory T cells in vivo in human skin. Sci Rep. 2020; 10(1):11164. PMC: 7341892. DOI: 10.1038/s41598-020-67430-7. View

4.
Taube J, Anders R, Young G, Xu H, Sharma R, McMiller T . Colocalization of inflammatory response with B7-h1 expression in human melanocytic lesions supports an adaptive resistance mechanism of immune escape. Sci Transl Med. 2012; 4(127):127ra37. PMC: 3568523. DOI: 10.1126/scitranslmed.3003689. View

5.
Mei Y, Bi W, Greenwald N, Du Z, Agar N, Kaiser U . Increased expression of programmed death ligand 1 (PD-L1) in human pituitary tumors. Oncotarget. 2016; 7(47):76565-76576. PMC: 5363530. DOI: 10.18632/oncotarget.12088. View